2023-08-01 2024-07-31 false Capium Accounts Production 1.1 08600837 2023-08-01 2024-07-31 08600837 bus:FullAccounts 2023-08-01 2024-07-31 08600837 bus:FRS102 2023-08-01 2024-07-31 08600837 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 08600837 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 08600837 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 08600837 2023-08-01 2024-07-31 08600837 2024-07-31 08600837 bus:RegisteredOffice 2023-08-01 2024-07-31 08600837 core:WithinOneYear 2024-07-31 08600837 core:AfterOneYear 2024-07-31 08600837 1 2023-08-01 2024-07-31 08600837 bus:Director1 2023-08-01 2024-07-31 08600837 bus:Director1 2024-07-31 08600837 bus:Director1 2022-08-01 2023-07-31 08600837 bus:Director2 2023-08-01 2024-07-31 08600837 bus:Director2 2024-07-31 08600837 bus:Director2 2022-08-01 2023-07-31 08600837 2022-08-01 08600837 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 08600837 2022-08-01 2023-07-31 08600837 2023-07-31 08600837 core:WithinOneYear 2023-07-31 08600837 core:AfterOneYear 2023-07-31 08600837 bus:EntityAccountantsOrAuditors 2022-08-01 2023-07-31 08600837 core:FurnitureFittings 2023-08-01 2024-07-31 08600837 core:FurnitureFittings 2024-07-31 08600837 core:FurnitureFittings 2023-07-31 08600837 core:ComputerEquipment 2023-08-01 2024-07-31 08600837 core:ComputerEquipment 2024-07-31 08600837 core:ComputerEquipment 2023-07-31 08600837 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-07-31 08600837 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-07-31 08600837 core:NetGoodwill 2023-08-01 2024-07-31 08600837 core:CostValuation core:Non-currentFinancialInstruments 2024-07-31 08600837 core:CostValuation core:Non-currentFinancialInstruments 2023-07-31 08600837 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-07-31 08600837 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 08600837 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-07-31 08600837 core:Non-currentFinancialInstruments 2024-07-31 08600837 core:Non-currentFinancialInstruments 2023-07-31 08600837 core:ShareCapital 2024-07-31 08600837 core:ShareCapital 2023-07-31 08600837 core:RetainedEarningsAccumulatedLosses 2024-07-31 08600837 core:RetainedEarningsAccumulatedLosses 2023-07-31 08600837 dpl:Item1 2023-08-01 08600837 dpl:Item1 2024-07-31 08600837 dpl:Item1 2022-08-01 08600837 dpl:Item1 2023-07-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 08600837
England and Wales

 

 

 

SURGICAL ARENA LTD



Unaudited Financial Statements
 


Period of accounts

Start date: 01 August 2023

End date: 31 July 2024
Directors Dr Darren Kaliany Patten
Dr Alia Ahmed
Registered Number 08600837
Registered Office 167-169 Great Portland Street, 5th Floor
London
W1W 5PF
Accountants Swenta Limited
167-169 Great Portland Street,
5th Floor, London
W1W 5PF
1
Accountants report
You consider that the company is exempt from an audit for the year ended 31 July 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account,  the Balance Sheet and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Swenta Limited
31 July 2024



....................................................

Swenta Limited

167-169 Great Portland Street,
5th Floor, London
W1W 5PF
23 May 2025
2
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 5,743    7,356 
5,743    7,356 
Current assets      
Debtors 4   1 
Cash at bank and in hand 4,071    17,827 
4,071    17,828 
Creditors: amount falling due within one year 5 (2,332)   (8,456)
Net current assets 1,739    9,372 
 
Total assets less current liabilities 7,482    16,728 
Net assets 7,482    16,728 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 7,382    16,628 
Shareholders' funds 7,482    16,728 
 


For the year ended 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 23 May 2025 and were signed on its behalf by:


-------------------------------
Dr Darren Kaliany Patten
Director
3
General Information
SURGICAL ARENA LTD is a private company, limited by shares, registered in England and Wales, registration number 08600837, registration address 167-169 Great Portland Street, 5th Floor, London, W1W 5PF.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Group accounts
The company is a parent company subject to the small companies regime. The company and its subsidiary comprise a small group. The company has, therefore, taken advantage of the option provided by section 398 of the Companies Act 2006 not to prepare group accounts.
Government grants
Government grants received are credited to deferred income. Grants towards capital expenditure are released to the income statement over the expected useful life of the assets. Grants received towards revenue expenditure are released to the income statement as the related expenditure is incurred.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Preference dividends
Where preference shares are classed as liabilities rather than equity any preference dividends paid are included in interest payable and similar charges within the income statement.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
2.

Average number of employees


Average number of employees during the year was 1 (2023 : 1).
3.

Tangible fixed assets

Cost or valuation Fixtures and Fittings   Computer Equipment   Total
  £   £   £
At 01 August 2023 6,270    22,946    29,216 
Additions    
Disposals    
At 31 July 2024 6,270    22,946    29,216 
Depreciation
At 01 August 2023 2,939    18,921    21,860 
Charge for year 607    1,006    1,613 
On disposals    
At 31 July 2024 3,546    19,927    23,473 
Net book values
Closing balance as at 31 July 2024 2,724    3,019    5,743 
Opening balance as at 01 August 2023 3,331    4,025    7,356 


4.

Debtors: amounts falling due within one year

2024
£
  2023
£
Other Debtors   1 
  1 

5.

Creditors: amount falling due within one year

2024
£
  2023
£
Corporation Tax 2,332    5,896 
Directors' Current Accounts   2,560 
2,332    8,456 

4